Skip to content

Upper extremity pain management with stellate ganglion block

Clinical trial of Comparison of effectiveness of stellate ganglion block under the guidance of fluoroscopy and ultrasonography guidance in upper extremity complex regional pain syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012081410599N1
Enrollment
14
Registered
2015-01-30
Start date
2014-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Extremities Complex regional pain syndrome. Pain in limb

Interventions

Intervention 1: Flouroscopic guide stellate ganglion block: After select the patient with block randomization method, first put the C-ARM in AP view and specify the C6 or C7 vertebra. The desired
Treatment - Other
Flouroscopic guide stellate ganglion block: After select the patient with block randomization method, first put the C-ARM in AP view and specify the C6 or C7 vertebra. The desired location is the
Sono guide stellate ganglion block: After select the patient with block randomization method,the patient is placed in supine position with little head extension to contralateral side . We used the l

Sponsors

Vice chancellor for research, Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Type1 and 2 CRPS, post-herpetic neuralgia, head and neck and upper limbs cancer pain, vascular pain, hyperhydrosis, vascular vasospasm, vasculopathy related Menier disease, post traumatic syndromes which cause cyanosis, cold hydrosis and inflammation. Exclusion criteria : anticoagulant therapy, pneumothorax or pneumonectomy in other side, recent MI, glaucoma and cardiac conduction anomaly.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: First , 6 hours and 2-7 days after that. Method of measurement: VAS ( standard tools for pain assessment).;Affected upper extremity temperature. Timepoint: First , 6 hours and 2-7 days after that. Method of measurement: Thermometer.

Secondary

MeasureTime frame
Conjunctival and nasal congestion. Timepoint: Immediately after injection. Method of measurement: Visual.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactkarim Hemati

Iran University of Medical Sciences

khematy@gmail.com+98 21 6655 3921

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026